Insight

Jordan Hansford: The importance of rigorous trials with “new” and novel agents

Photo of Jordan Hansford from vicpcc.org

Aug 11, 2024, 12:18

Jordan Hansford: The importance of rigorous trials with “new” and novel agents

Jordan Hansford, McClurg Brain Cancer Fellow at SAHMRI, shared on X about a recent paper titled “Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201” published in Journal of Clinical Oncology.

Authors: Jordan Hansford et al.

The importance

“Our review out in Journal of Clinical Oncology on the importance of rigorous trials with ‘new’ and novel agents led by Prof Eric Bouffet Vijay, Ramaswamy, Gauthier Bouche, Nada Jabado and I.”

Source: Jordan Hansford/X

Adriana Fonseca Amar Gajjar cancer Christopher Tinkle Darren Hargrave David Ashley David Eisenstat David Ziegler Eric Bouffet Gauthier Bouche Giles Robinson Jordan Hansford Journal of Clinical Oncology Maryam Fouladi Maura Massimino Nada Jabado Nicholas Foreman Nicholas Gottardo Olaf Witt OncoDaily Oncology Paul Fisher SAHMRI Sam Moloney Stefan Pfister Stefan Rutkowski Ute Bartels Vijay Ramaswamy

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage